Northvane

Treatment guide

Therapeutic plasma exchange (TPE)

What happens in a session, where plasma exchange is established medicine, what private clinics offer it for, and what the research does and does not show yet.

Updated Nov 17, 2026

The short answer

Therapeutic plasma exchange removes the liquid part of your blood, the plasma, with an apheresis machine and replaces it, usually with a purified albumin solution, while your blood cells go back into your body. It is an established hospital treatment for specific diseases. Private clinics now also sell it for longevity and "detox", where the human evidence is early and mostly measures biomarkers, not health outcomes.

What is therapeutic plasma exchange?

Therapeutic plasma exchange, often shortened to TPE or PLEX and sometimes called plasmapheresis, is a medical procedure that takes blood out of a vein, separates the plasma from the blood cells, removes the plasma and returns the cells with a replacement fluid[1]. Plasma carries proteins, antibodies, fats and many other circulating molecules, so removing a large share of it lowers the level of whatever it carries, good and bad, until the body makes more.

How therapeutic plasma exchange worksBlood flows from the patient to a separator. Plasma is removed to a waste bag. Blood cells are returned to the patient together with replacement fluid such as albumin.Patientarm vein outwhole bloodSeparatorcentrifuge or membraneplasmaPlasma removedto waste bagReplacement fluidusually 5% albuminreturned
Plasma exchange: the patient's plasma is discarded and replaced. Schematic, not to scale.

The terms overlap. "Plasmapheresis" can also describe collecting plasma from donors, which is a different procedure with a different purpose. We explain the distinction in plasmapheresis vs plasma exchange.

What happens during a session?

A session usually lasts a few hours[1]. Private clinics listed on Northvane give session times from about 90 minutes to four hours, depending on how much plasma they process and how they count arrival and setup. Most use two peripheral IV lines, one to draw blood and one to return it; some patients need a central line, which carries a small risk of infection and bleeding[1].

  • Separation. Centrifugal machines such as the Terumo Spectra Optia spin blood to separate plasma; others use membranes. Both device families hold FDA 510(k) clearances as therapeutic separators[4],[5].
  • Replacement fluid. Private clinics that state it use 5% albumin, sometimes with saline. Donor plasma is used in some hospital indications; Reborne in London states it does not use donor plasma[7].
  • Volume. Clinics describe exchanges by plasma volume (for example 1.0 or 1.5 plasma volumes) or by liters. A low-volume session of about a liter processes much less and costs less, so it is a different dose, not a cheaper version of the same thing. Ask how much will be processed.

Where is plasma exchange established medicine?

The American Society for Apheresis grades the evidence for apheresis disease by disease. Its 2026 guidelines, the Tenth Special Issue, cover 93 fact sheets and 183 graded and categorized indications[2]. These are specific conditions, mainly neurological, blood, kidney and immune disorders, usually treated in hospital apheresis units. The FDA, for example, lists plasma exchange for thrombotic thrombocytopenic purpura among accepted uses of plasma[3].

"Longevity" and "healthy aging" are not disease indications. Next Health, one of the largest private providers, describes its longevity use of TPE as off-label[6], and Reborne in London excludes healthy ageing as a reason to treat[7].

What does the evidence show for longevity?

The most cited human study is a 2025 randomized, placebo-controlled trial in Aging Cell. It randomized 42 healthy adults over 50 to biweekly TPE with or without intravenous immunoglobulin (IVIG), monthly TPE, or placebo, and reported that 15 epigenetic clocks moved in the younger direction compared with placebo[8]. Three cautions matter:

  • Epigenetic clocks are biomarkers. A change in a clock is not evidence of longer life or fewer diseases.
  • The trial was small and single-blinded, and the combined TPE-plus-IVIG arm did best, so the effect of TPE alone is less clear.
  • Three of the authors are members of Circulate, a company that supplies plasma exchange to clinics[8].

In Alzheimer's disease, the AMBAR trial randomized 347 patients and reported 52% less decline on a daily-living measure than placebo at 14 months, with effects in moderate but not mild disease[9]. Clinics sometimes quote these figures for healthy people; AMBAR did not study healthy people.

For long COVID, a 2025 double-blind trial gave 50 patients six sessions of TPE or a sham procedure and found no difference in any efficacy measure[10].

For microplastics, a 2026 study measured circulating particles before and after 174 one-plasma-volume procedures in 114 patients and found they fell, although plastic leaching from the tubing set obscured the change when starting levels were low[11]. For PFAS ("forever chemicals"), the evidence that removing plasma lowers blood levels comes mainly from blood and plasma donation and filtration studies, summarized in a 2026 review[12]. Neither shows a health benefit yet.

What TPE is not

  • Not plasma donation. Donors give plasma for others; nothing is replaced in the same way and the goal is collection.
  • Not young-donor plasma. Infusing plasma from young donors is a different intervention. The FDA warned in 2019 that it has no proven clinical benefit for aging or memory loss[3]. That warning is not about plasma exchange with albumin.
  • Not dialysis. Dialysis filters waste products the kidneys normally clear; it does not remove plasma proteins.
  • Not PRP or EBOO. Platelet-rich plasma injections and ozone blood treatments are unrelated procedures.
  • Not INUSpheresis. INUSpheresis filters plasma and gives it back instead of replacing it. See INUSpheresis vs plasma exchange.

What are the risks and side effects?

During treatment people may feel cold or nauseated or notice tingling around the lips, hands or feet[1]. Clinics describe these as calcium-related symptoms, and careful programs monitor calcium during longer sessions. Clinics list fatigue, bruising at the needle sites, dizziness and fainting, and rarely more serious reactions. In the 2025 longevity trial, two adverse events led participants to stop[8]; in the long COVID trial, safety was similar with real and sham treatment[10]. Risk is higher with age, frailty, heart disease and some blood pressure medicines, which is why a careful clinic examines you, reviews your medicines and checks your blood first[7]. For a fuller account, read our guide to plasma exchange side effects.

Yes. TPE is performed in US hospitals, and private clinics offer it to self-paying patients; 7 such providers with US locations are listed on Northvane. What the FDA clears is the device[4],[5]; clearance does not mean the agency has approved or found effective every use a clinic advertises. Using TPE for longevity is off-label, and claims made for it are the clinic's own.

How much does therapeutic plasma exchange cost?

Among clinics that list a price online, one session costs from about $3,500 to $12,000, or works out at that within a series. Several of the largest providers quote only after a consultation. Packages differ in what they include (consultation, testing, number of sessions), so compare them line by line. Our plasma exchange cost guide compares every listed price on the same basis.

How do I choose a clinic?

Start with what a clinic will put in writing: who supervises, which device, how much plasma, which replacement fluid, which tests before and after, the emergency plan and the full price. Each profile in our list of plasma exchange clinics sets out the options, prices and team, with questions tailored to that clinic.

Sources

  1. [1]Plasma Exchange (Plasmapheresis) · American College of Rheumatology patient information (written July 2025) · 2025 · read Nov 17, 2026
  2. [2]Guidelines on the Use of Therapeutic Apheresis in Clinical Practice: The Tenth Special Issue · Journal of Clinical Apheresis (American Society for Apheresis), Zantek ND et al. · 2026 · read Nov 17, 2026
  3. [3]Important Information about Young Donor Plasma Infusions for Profit · U.S. Food and Drug Administration · 2019 · read Nov 17, 2026
  4. [4]510(k) K071079: Spectra Optia Apheresis System (product code LKN, therapeutic blood cell and plasma separator) · U.S. Food and Drug Administration 510(k) database · 2007 · read Nov 17, 2026
  5. [5]510(k) K111702: AMICUS Separator System, use in therapeutic plasma exchange · U.S. Food and Drug Administration 510(k) database · 2012 · read Nov 17, 2026
  6. [6]Plasma Exchange (TPE) · Next Health · 2026 · read Nov 17, 2026
  7. [7]Therapeutic Plasma Exchange · Reborne Longevity · 2026 · read Nov 17, 2026
  8. [8]Multi-Omics Analysis Reveals Biomarkers That Contribute to Biological Age Rejuvenation in Response to Single-Blinded Randomized Placebo-Controlled Therapeutic Plasma Exchange · Aging Cell 24(8):e70103, Fuentealba M, Kiprov D, et al. PMID 40424097 · 2025 · read Nov 17, 2026
  9. [9]A randomized, controlled clinical trial of plasma exchange with albumin replacement for Alzheimer's disease: Primary results of the AMBAR Study · Alzheimer's & Dementia 16(10):1412-1425, Boada M et al. PMID 32715623 · 2020 · read Nov 17, 2026
  10. [10]Plasma exchange therapy for the post COVID-19 condition: a phase II, double-blind, placebo-controlled, randomized trial · Nature Communications 16:1929, España-Cueto S et al. PMID 39994269 · 2025 · read Nov 17, 2026
  11. [11]Can Plasma Exchange Be Used to Lower the Circulating Burden of Microplastics in Human Patients? · Journal of Clinical Apheresis 41(3):e70135, Weinstein R et al. PMID 42169439 · 2026 · read Nov 17, 2026
  12. [12]Role of Therapeutic Plasma Exchange in Accelerating the Clearance of Perfluoroalkyl and Polyfluoroalkyl Substances · Cureus 18(9):e116975, Baykara Y. PMID 42936874 · 2026 · read Nov 17, 2026